| Name | 1-{4-[(13C,2H3)Methyloxy]phenyl}-7-oxo-6-[4-(2-oxo-1-piperidinyl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide |
|---|---|
| Synonyms |
1-{4-[(13C,2H3)Methyloxy]phenyl}-7-oxo-6-[4-(2-oxo-1-piperidinyl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide
1H-Pyrazolo[3,4-c]pyridine-3-carboxamide, 4,5,6,7-tetrahydro-1-[4-(methyl-13C-d3-oxy)phenyl]-7-oxo-6-[4-(2-oxo-1-piperidinyl)phenyl]- |
| Description | Apixaban 13CD3 (BMS-562247-01 13CD3) is a deuterium labeled Apixaban. Apixaban is a highly selective, reversible inhibitor of Factor Xa with Ki of 0.08 nM and 0.17 nM in human and rabbit, respectively[1]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.4±0.1 g/cm3 |
|---|---|
| Molecular Formula | C2413CH22D3N5O4 |
| Molecular Weight | 463.508 |
| Exact Mass | 463.212830 |
| Index of Refraction | 1.705 |
| Hazard Codes | Xi |
|---|